lobbying_activities: 2783021

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2783021	bca3f9d5-4361-4a8c-b027-9147776d2da5	Q1	U.S. PUBLIC INTEREST RESEARCH GROUP	38814	U.S. PUBLIC INTEREST RESEARCH GROUP	2022	first_quarter	TOB	Signed numerous letters urging FDA to move quickly to eliminate menthol cigarettes, and lobbied Congress to give FDA authority to regulate synthetic nicotine products as tobacco products.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		20000	0	0	2022-04-19T11:02:11-04:00